Localized periadventitial delivery of non-cytotoxic PGG early after injury inhibits elastin degeneration and attenuates AAA growth, indicating that targeted wall exposure can modify disease trajectory even without systemic drug levels [94]. The gene discussed is ELN; the disease is triple-A syndrome.